Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock $0.001 par value
-
Shares outstanding
-
28M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
1.71M
-
Shares change
-
-67.1K
-
Total reported value, excl. options
-
$1.23M
-
Value change
-
-$48.2K
-
Number of buys
-
12
-
Number of sells
-
-3
-
Price
-
$0.72
Significant Holders of GEOVAX LABS, INC. - Common Stock $0.001 par value (BLCM) as of Q4 2022
28 filings reported holding BLCM - GEOVAX LABS, INC. - Common Stock $0.001 par value as of Q4 2022.
GEOVAX LABS, INC. - Common Stock $0.001 par value (BLCM) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.71M shares
of 28M outstanding shares and own 6.08% of the company stock.
Largest 10 shareholders include Ikarian Capital, LLC (448K shares), Long Focus Capital Management, LLC (328K shares), BAKER BROS. ADVISORS LP (249K shares), VANGUARD GROUP INC (182K shares), BlackRock Inc. (75.9K shares), GEODE CAPITAL MANAGEMENT, LLC (72.8K shares), Boxer Capital, LLC (57K shares), BOOTHBAY FUND MANAGEMENT, LLC (45.1K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (42.3K shares), and HRT FINANCIAL LP (36.5K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.